Total Funding
60
62
Total FundingSeed raised
Growth Score
-21 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
15294
Persephone Biosciences uses artificial intelligence to rapidly develop microbial based immunotherapies to enable a lifetime without cancer.
- Steve Dien: Co-Founder and CTO
- Stephanie Culler: Co-Founder and CEO
About the Company
Persephone Biosciences develops healthcare technology designed to focus on microbial therapeutics for immuno-oncology applications. The company's technology uses artificial intelligence and omics techniques on multiple cancer patient gut microbiome and blood samples to identify microbes needed for normal immune function for population-scale
patient data analytics, enabling lab researchers to design microbial drugs that prevent and fight cancer.
Persephone Biosciences was founded in 2017 and is based in San Diego, California.
Women Founded
Women Led
